Details for Patent: 9,486,530
✉ Email this page to a colleague
Which drugs does patent 9,486,530 protect, and when does it expire?
Patent 9,486,530 protects GANZYK-RTU and is included in one NDA.
Summary for Patent: 9,486,530
Title: | Ganciclovir compositions and related methods |
Abstract: | Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided. |
Inventor(s): | Mallipeddi; Sreerama Murthy (Hickory, NC), Sterling; Jonathan E. (Morganton, NC), Koneru; Phanesh B. (Ashburn, VA) |
Assignee: | Exela Pharma Sciences, LLC (Ashburn, VA) |
Application Number: | 14/475,206 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,486,530
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | GANZYK-RTU | ganciclovir | SOLUTION;INTRAVENOUS | 209347-001 | Feb 17, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |